GR3026546T3 - Multilayer matrix systems for the controlled release of active principles. - Google Patents

Multilayer matrix systems for the controlled release of active principles.

Info

Publication number
GR3026546T3
GR3026546T3 GR980400732T GR980400732T GR3026546T3 GR 3026546 T3 GR3026546 T3 GR 3026546T3 GR 980400732 T GR980400732 T GR 980400732T GR 980400732 T GR980400732 T GR 980400732T GR 3026546 T3 GR3026546 T3 GR 3026546T3
Authority
GR
Greece
Prior art keywords
active principles
layer
controlled release
matrix systems
multilayer matrix
Prior art date
Application number
GR980400732T
Other languages
English (en)
Inventor
Paolo Colombo
Cardona Antonio Corvi
Giorgio Pifferi
Original Assignee
Inverni Della Beffa Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11364297&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3026546(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Inverni Della Beffa Spa filed Critical Inverni Della Beffa Spa
Publication of GR3026546T3 publication Critical patent/GR3026546T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Networks Using Active Elements (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Cephalosporin Compounds (AREA)
GR980400732T 1992-11-17 1998-04-06 Multilayer matrix systems for the controlled release of active principles. GR3026546T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922617A IT1256393B (it) 1992-11-17 1992-11-17 Forme matriciali multistrato per il rilascio controllato di principi attivi

Publications (1)

Publication Number Publication Date
GR3026546T3 true GR3026546T3 (en) 1998-07-31

Family

ID=11364297

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980400732T GR3026546T3 (en) 1992-11-17 1998-04-06 Multilayer matrix systems for the controlled release of active principles.

Country Status (9)

Country Link
US (1) US5549913A (el)
EP (1) EP0598309B1 (el)
JP (2) JP3496961B2 (el)
AT (1) ATE162711T1 (el)
DE (1) DE69316715T2 (el)
DK (1) DK0598309T3 (el)
ES (1) ES2112946T3 (el)
GR (1) GR3026546T3 (el)
IT (1) IT1256393B (el)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
DE19524753A1 (de) * 1995-07-07 1997-01-23 Lohmann Therapie Syst Lts Schichttablette zur kontrollierten Freisetzung von Wirkstoffen
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
AU5609998A (en) * 1997-01-10 1998-08-03 Abbott Laboratories Tablet for the controlled release of active agents
IT1295271B1 (it) * 1997-10-03 1999-05-04 Chiesi Farma Spa Monolita contenente uno o piu'farmaci costituito da tre strati a meccanismo di rilascio differenziato
US6337091B1 (en) * 1997-10-27 2002-01-08 Temple University - Of The Commonwealth System Of Higher Education Matrix for controlled delivery of highly soluble pharmaceutical agents
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
DE60123384T2 (de) * 2000-02-04 2007-08-02 DepoMed, Inc., Menlo Park Dosierungsform des typs "hülle und kern" mit einer wirkstofffreisetzung, die sich der nullten ordnung annähert
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
KR100685945B1 (ko) 2000-12-29 2007-02-23 엘지.필립스 엘시디 주식회사 액정표시장치 및 그 제조방법
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
ITMI20012481A1 (it) 2001-11-23 2003-05-23 Univ Parma Sistemi modulari per il rilascio controllato di sostanza a controllo spaziale e temporale
US6682759B2 (en) 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
US6852238B2 (en) * 2002-08-29 2005-02-08 Steller Technology Company Layered tablet water treatment compositions and method of use
US7309444B2 (en) * 2002-08-29 2007-12-18 Stellar Technology Company Layered tablet water treatment compositions and method of use
PL1617832T3 (pl) 2003-04-29 2009-01-30 Orexigen Therapeutics Inc Kompozycje wpływające na utratę wagi
US20040241234A1 (en) * 2003-06-02 2004-12-02 Alpharma, Inc. Controlled release press-coated formulations of water-soluble active agents
US20050013863A1 (en) * 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
WO2006010640A1 (en) * 2004-07-29 2006-02-02 Sanofi-Aventis Pharmaceutical multilayer tablet for controlled release of active ingredients with highly ph-dependent solubility
US20060024368A1 (en) * 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
ATE401868T1 (de) * 2004-08-04 2008-08-15 Alza Corp ZUSAMMENSETZUNG MIT VERZÖGERTER ARZNEIMITTELFREISETZUNG MIT EINEM AUFSTEIGENDEN NULLORDNUNG-FREIGABE-MUSTER; VERFAHREN ZUR HERSTELLUNG EINER SOLCHEN ZUSAMMENSETZUNGß
ES2516644T3 (es) * 2004-11-19 2014-10-31 Glaxosmithkline Llc Producto farmacéutico
US9029427B2 (en) * 2005-11-11 2015-05-12 Asahi Kasei Chemicals Corporation Controlled release solid preparation
EP1948138A4 (en) * 2005-11-18 2012-07-11 Accu Break Technologies Inc SEGMENTED PHARMACEUTICAL FORMS
BRPI0618687A2 (pt) 2005-11-18 2011-09-06 Glaxo Group Ltd máquina e método para montagem de produto farmacêutico e produto tipo farmacêutico
EP3132792B1 (en) 2005-11-22 2019-09-11 Nalpropion Pharmaceuticals, Inc. Composition and methods for increasing insulin sensitivity
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
CA2657437A1 (en) * 2006-06-19 2007-12-27 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
AU2007319472B2 (en) 2006-11-09 2013-01-17 Nalpropion Pharmaceuticals Llc Methods Of Administering Weight Loss Medications
KR101479324B1 (ko) * 2006-11-09 2015-01-05 오렉시젠 세러퓨틱스 인크. 신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
US20100322978A1 (en) * 2006-12-27 2010-12-23 Fujifilm Corporation Medical composition
KR100885029B1 (ko) * 2007-02-07 2009-02-23 지엘팜텍 주식회사 경구투여용 서방성 삼중정제
PL3050568T3 (pl) 2007-03-13 2021-06-14 Jds Therapeutics, Llc Sposoby i kompozycje do przedłużonego uwalniania chromu
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
US20130079749A1 (en) * 2007-08-29 2013-03-28 Advanced Bionics, Llc Modular Drug Delivery System for Minimizing Trauma During and After Insertion of a Cochlear Lead
KR20100133969A (ko) * 2008-02-04 2010-12-22 테바 위민즈 헬스 인코포레이티드 프로게스테론 함유 단일형 질내 링 및 그의 제조방법과 용도
WO2009118763A1 (en) * 2008-03-28 2009-10-01 Panacea Biotec Limited Multilayered pharmaceutical compositions and processes thereof
US20110144145A1 (en) 2008-05-30 2011-06-16 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
WO2010005732A2 (en) * 2008-06-16 2010-01-14 Appian Labs, Llc Composition and method of preparation of release systems for constant (zero-order) release of active agents
US20110195116A1 (en) * 2008-08-19 2011-08-11 Adcock Ingram Healthcare Pty Limited Rate modulated delivery of drugs from a composite delivery system
EP2163240A1 (en) 2008-09-12 2010-03-17 Universita' Degli Studi Di Genova A method for the production of bioadhesive compact matrices
WO2010048478A2 (en) * 2008-10-23 2010-04-29 Appian Labs, Llc Tablets and discs with compartments with two or more drugs for release at certain intervals and with specific rates
BRPI0906820A2 (pt) * 2009-12-21 2013-07-30 Inst Presbiteriano Mackenzie matriz cerÂmica para incorporar fÁrmacos de liberaÇço controlada, comprimido, mÉtodo para obtenÇço da matriz cerÂmica e mÉtodo para produzir um comprimido
BR112012016783A2 (pt) 2010-01-11 2015-09-01 Orexigen Therapeutics Inc "usos do composto de naltrexona ou sal farmaceuticamente aceitável da mesma a bupropiona ou sal farmaceuticamente aceitável da mesma ou de composição dos mesmos e métodos para proporcionar terapia"
EP2826468A1 (en) 2010-12-22 2015-01-21 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
NZ612996A (en) 2010-12-23 2015-05-29 Purdue Pharma Lp Tamper resistant solid oral dosage forms
US9622979B2 (en) * 2011-06-29 2017-04-18 Sun Pharmaceutical Industries Limited Multilayered dosage form
WO2013006470A1 (en) * 2011-07-01 2013-01-10 Gelita Ag Novel gelatin capsule compositions and methods of making
US20140377347A1 (en) 2012-01-23 2014-12-25 Ranbaxy Laboratories Limited In-situ multilayered tablet technology
LT2858640T (lt) 2012-06-06 2020-08-10 Nalpropion Pharmaceuticals Llc Kompozicija, skirta panaudoti pacientų su aukšta širdies ir kraujagyslių ligų rizika antsvorio ir nutukimo gydymo būde
EA201500742A1 (ru) 2013-02-05 2015-12-30 Пердью Фарма Л.П. Защищенные от нецелевого использования фармацевтические композиции
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
GB2564295A (en) 2016-02-11 2019-01-09 Nutrition 21 Llc Chromium containing compositions for improving health and fitness

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL109293C (el) * 1955-12-22
US4869908A (en) * 1987-01-09 1989-09-26 K.V. Pharmaceutical Co. Fibre formulations
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive

Also Published As

Publication number Publication date
US5549913A (en) 1996-08-27
DE69316715D1 (de) 1998-03-05
JPH072649A (ja) 1995-01-06
ITMI922617A1 (it) 1994-05-17
JP3496961B2 (ja) 2004-02-16
ES2112946T3 (es) 1998-04-16
ITMI922617A0 (it) 1992-11-17
IT1256393B (it) 1995-12-04
DK0598309T3 (da) 1998-09-21
EP0598309A2 (en) 1994-05-25
ATE162711T1 (de) 1998-02-15
JP2004107351A (ja) 2004-04-08
EP0598309A3 (en) 1994-06-01
EP0598309B1 (en) 1998-01-28
DE69316715T2 (de) 1998-07-16

Similar Documents

Publication Publication Date Title
EP0598309A3 (en) Multilayer matrix systems for the controlled release of active principles.
EP0213083A3 (en) Controlled release tablet
EP0147780A3 (en) Drug delivery device
ES2138584T3 (es) Sistema de suministro de farmacos que implica la reaccion entre una proteina o un polipeptido y un polimero biodegradable hidrofobo.
CA2226718A1 (en) Transcorneal drug-release system
PT887074E (pt) Dispositivo de administracao intravaginal de farmaco
IT1239266B (it) Sistema di chiamata di emergenza di gruppo.
CA2269707A1 (en) Soluble form osmotic dose delivery system
DK288987D0 (da) Et afgivelsessystem til doseringsformerne forhalet afgivelse, samt dettes fremstilling
FR2784583B1 (fr) Composition pharmaceutique a residence gastrique et a liberation controlee
HK1039054A1 (en) Controlled release tablet comprising a hypoglycemic drug and an antihyperglycemic drug.
HU9601474D0 (en) Device for effecting the controlled release of active substances
GB2210884B (en) Granules based on hydrophilic polymers on which an aqueous formulation, containing one or more active principles, is absorbed
HUT75029A (en) Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient
FR2686674B1 (fr) Valve pivotante, notamment pour dispositifs de sauvetage gonflables.
ATE213933T1 (de) Orale zubereitung, enthaltend in einer in wässrigem medium quellbaren matrix wenigstens einen pharmazeutischen wirkstoff
EP0659077A4 (en) PILOCARPIN DELIVERY SYSTEM WITH CONTROLLED RELEASE.
IT1275267B (it) Forme farmaceutiche a rilascio modificato di canrenoato di potassio costituite da matrici idrofile rivestite
Likes Evacuation- Airframe manufacturer's viewpoint
ITRM930177A0 (it) Sistema automatico di allarme e di richiesta di soccorso (mayday) per imbarcazioni.
DE59409014D1 (de) Antiblockierregelsysteme mit zeitbegrenzung des ersten bremsdruckabbaus
IT8902942A0 (it) Sistema di pulitura per superfici di laghi e mari, e mezzi attuatori.
ITRM920395A1 (it) Natante da pesca e/o per trasporto passeggeri attrezzato antiribaltamento.